Back to Landing Page »

A Case Based Approach For the Treatment of Hyperkalemia in Patients with Heart Failure

Dr. Heywood

Relypsa, a Vifor Pharma Group company, aims to focus in iron deficiency, nephrology and cardio-renal therapeutic areas. We strive to help improve the lives of patients with severe and chronic diseases. The materials and content in this virtual exhibit are intended for US Healthcare professionals only. If you are not a US Healthcare professional, please visit


Relypsa Veltassa Full Prescribing Information »

Relypsa SNAP OPAL Flashcard »

Relypsa $0 Co-Pay Savings Program Flashcard »


November 11, 2020

Created by

Scripps CME Connection